J&J | JNJ - Creditori Commerciali





Creditori Commerciali Cambiamento Data
AbbVie USD 3.59B 28.65B 2025-12
Abbott USD 4.68B 439M 2026-03
Amgen USD 2.86B 16.65B 2026-06
AstraZeneca USD 22.89B 388M 2026-06
Baxter International USD 1.03B 52M 2026-06
Bayer EUR 6.39B 192M 2026-06
Becton, Dickinson and Co. USD 6.11B 173M 2026-06
Biogen USD 403.9M 45.4M 2026-06
Boston Scientific USD 1.23B 90M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
CONMED USD 101.02M 4.4M 2026-06
Cooper Companies USD 251.2M 17.9M 2026-06
Dexcom USD 2.08B 134.8M 2026-06
Edwards Lifesciences USD 210.5M 29.4M 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
Globus Medical USD 106.94M 3.28M 2026-06
Insulet USD 123.3M 26.5M 2026-06
Integra LifeSciences USD 82.64M 5.31M 2026-06
Intuitive Surgical USD 1.92B 66.6M 2026-06
J&J USD 9.22B 1.24B 2026-06
Medtronic USD 2.7B 51M 2026-06
Merck USD 3.83B 36M 2026-06
Merit Medical Systems USD 70.74M 2.88M 2026-06
Novartis USD 4.26B 64M 2026-06
Pfizer USD 4.58B 75M 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sanofi EUR 23.6B 888M 2026-06
Stryker USD 1.59B 207M 2026-03
Tandem Diabetes Care USD 64.13M 4.27M 2026-06
Teva Pharmaceutical Industries USD 2.72B 125M 2026-06
Vertex Pharmaceuticals USD 3.61B 135M 2026-06
Zimmer Biomet Holdings USD 352.4M 8.8M 2026-06
Zoetis USD 452M 55M 2026-06